Open | - |
Close | - |
Volume / Avg. | 0 / 88.339K |
Day Range | - - - |
52 Wk Range | 2.730 - 6.290 |
Market Cap | $180.107M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 1.76% |
Days to Cover | 7.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Harvard Bioscience (NASDAQ: HBIO) through any online brokerage.
Other companies in Harvard Bioscience’s space includes: Codexis (NASDAQ:CDXS), Personalis (NASDAQ:PSNL), Mesa Laboratories (NASDAQ:MLAB), Quantum-Si (NASDAQ:QSI) and Inotiv (NASDAQ:NOTV).
The latest price target for Harvard Bioscience (NASDAQ: HBIO) was reported by Benchmark on Thursday, June 22, 2023. The analyst firm set a price target for 7.00 expecting HBIO to rise to within 12 months (a possible 68.67% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Harvard Bioscience (NASDAQ: HBIO) is $4.15 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Harvard Bioscience.
Harvard Bioscience’s Q1 earnings are confirmed for Tuesday, April 23, 2024.
There is no upcoming split for Harvard Bioscience.
Harvard Bioscience is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.